Literature DB >> 28407456

3-Nitro-2-pyridinesulfenates as Efficient Solution- and Solid-Phase Disulfide Bond Forming Agents.

Akihiro Taguchi1, Kiyotaka Kobayashi1, Akira Kotani2, Kyohei Muguruma1, Misaki Kobayashi1, Kentarou Fukumoto1,3, Kentaro Takayama1, Hideki Hakamata2, Yoshio Hayashi1.   

Abstract

In this paper, a new disulfide-forming agent based on the finding that alkoxy 3-nitro-2-pyridinesulfenates (Npys-OR) can oxidize thiol groups is reported. Methyl 3-nitro-2-pyridinesulfenate (Npys-OMe), which is easily prepared from 3-nitro-2-pyridinesulfenyl chloride in a one-step reaction and has a reduction peak potential (Epc ) of -0.541 V versus Ag/AgCl, produces the cyclic nonapeptide oxytocin from its linear form in good yield (92 %) with minimal oligomer formation. Npys-OMe in the solid phase also demonstrated excellent results in oxytocin synthesis. Other disulfide-containing peptides, such as α-human atrial natriuretic peptide and α-conotoxin ImI, were also successfully synthesized. During these syntheses, no side reactions of methionine (Met) and tryptophan (Trp) residues or the S-acetamidomethyl (Acm) protecting group were detected. These results suggested that Npys-OMe or its solid-phase analog provides a new strategy for regioselective disulfide bond formation to assist the synthesis of complex disulfide-rich peptides.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  3-nitro-2-pyridinesulfenyl; disulfide bond formation; oxidation; peptides; solid-phase synthesis

Year:  2017        PMID: 28407456     DOI: 10.1002/chem.201700952

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Synthesis and structure-activity relationship studies of IgG-binding peptides focused on the C-terminal histidine residue.

Authors:  Kyohei Muguruma; Mayu Ito; Akane Fukuda; Satoshi Kishimoto; Akihiro Taguchi; Kentaro Takayama; Atsuhiko Taniguchi; Yuji Ito; Yoshio Hayashi
Journal:  Medchemcomm       Date:  2019-08-01       Impact factor: 3.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.